HomeNewsBusinessEarningsAurobindo Pharma FY11 PAT seen dn 0.35% at Rs 561 cr
Trending Topics
Q2 Results Live
Bharti Airtel Q2 Results
Tata Consumer Q2 Results
Bank of Baroda Q2 Results

Aurobindo Pharma FY11 PAT seen dn 0.35% at Rs 561 cr

Aurobindo Pharma is to announce its FY11 revenues are seen up 20% at Rs 4276 crore versus Rs 3575 crore.

May 09, 2011 / 17:28 IST
Story continues below Advertisement
Remove Ad

Aurobindo Pharma is to announce its FY11 revenues are seen up 20% at Rs 4276 crore versus Rs 3575 crore.

Its EBITDA is seen up 16% to Rs 955 crore versus Rs 823 crore. The company's OPM is seen down 22.3% versus 23%. The company's PAT is seen down 0.35% at Rs 561 crore versus Rs 563 crore.
first published: May 9, 2011 05:26 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today Coforge Share Price Ola Electric Share Price Gold Rate Today Silver Price Today Vijay Hazare Trophy Ganesh Uike Train Fare Hike news Sheikh Hasina Udaipur gang rape
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.